{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:57:05Z","timestamp":1775123825976,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Excellent Clinical Medicine Talent Training Project of Hebei Province","award":["ZF2024018"],"award-info":[{"award-number":["ZF2024018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Brain Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00221-026-07257-2","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:12:02Z","timestamp":1772183522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KDM6B promotes VEGFA expression and vasculogenic mimicry in glioblastoma cells under hypoxia conditions"],"prefix":"10.1007","volume":"244","author":[{"given":"Jie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aixia","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"1","key":"7257_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13148-022-01305-8","volume":"14","author":"J Abu-Hanna","year":"2022","unstructured":"Abu-Hanna J, Patel JA, Anastasakis E et al (2022) Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature. Clin Epigenetics 14(1):98","journal-title":"Clin Epigenetics"},{"issue":"5","key":"7257_CR2","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","volume":"57","author":"BK Ahir","year":"2020","unstructured":"Ahir BK, Engelhard HH, Lakka SS (2020) Tumor development and angiogenesis in adult brain tumor: glioblastoma. Mol Neurobiol 57(5):2461\u20132478","journal-title":"Mol Neurobiol"},{"key":"7257_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fonc.2020.00220","volume":"10","author":"MA Andonegui-Elguera","year":"2020","unstructured":"Andonegui-Elguera MA, Alfaro-Mora Y, C\u00e1ceres-Guti\u00e9rrez R et al (2020) An overview of vasculogenic mimicry in breast cancer. Front Oncol 10:220","journal-title":"Front Oncol"},{"issue":"6432","key":"7257_CR4","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1126\/science.aau5870","volume":"363","author":"M Batie","year":"2019","unstructured":"Batie M, Frost J, Frost M, Wilson JW, Schofield P, Rocha S (2019) Hypoxia induces rapid changes to histone methylation and reprograms chromatin. Science 363(6432):1222\u20131226","journal-title":"Science"},{"issue":"10","key":"7257_CR5","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00018-013-1283-7","volume":"70","author":"P Carmeliet","year":"2013","unstructured":"Carmeliet P, Ruiz de Almodovar C (2013) VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration. Cell Mol Life Sci 70(10):1763\u20131778","journal-title":"Cell Mol Life Sci"},{"issue":"6432","key":"7257_CR6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.aaw1026","volume":"363","author":"AA Chakraborty","year":"2019","unstructured":"Chakraborty AA, Laukka T, Myllykoski M et al (2019) Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science 363(6432):1217\u20131222","journal-title":"Science"},{"issue":"2","key":"7257_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5732\/cjc.012.10292","volume":"33","author":"YS Chen","year":"2014","unstructured":"Chen YS, Chen ZP (2014) Vasculogenic mimicry: a novel target for glioma therapy. Chin J Cancer 33(2):74\u201379","journal-title":"Chin J Cancer"},{"issue":"11","key":"7257_CR8","first-page":"496","volume":"34","author":"DH Chen","year":"2015","unstructured":"Chen DH, Zhang XS (2015) Targeted therapy: resistance and re-sensitization. Chin J Cancer 34(11):496\u2013501","journal-title":"Chin J Cancer"},{"key":"7257_CR9","doi-asserted-by":"publisher","first-page":"144994","DOI":"10.1016\/j.gene.2020.144994","volume":"759","author":"CI Cuzziol","year":"2020","unstructured":"Cuzziol CI, Castanhole-Nunes MMU, Pavarino \u00c9C et al (2020) MicroRNAs as regulators of VEGFA and NFE2L2 in cancer. Gene 759:144994","journal-title":"Gene"},{"issue":"3","key":"7257_CR10","first-page":"119","volume":"10","author":"SM Dang","year":"2024","unstructured":"Dang SM, Yang D, Wang ZY et al (2024) Vasculogenic mimicry: a pivotal mechanism contributing to drug resistance in antiangiogenic therapy. Oncol Transl Med 10(3):119\u2013125","journal-title":"Oncol Transl Med"},{"issue":"16","key":"7257_CR11","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMcibr1309402","volume":"369","author":"S Das","year":"2013","unstructured":"Das S, Marsden PA (2013) Angiogenesis in glioblastoma. N Engl J Med 369(16):1561\u20131563","journal-title":"N Engl J Med"},{"issue":"10","key":"7257_CR12","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.3390\/cancers12102792","volume":"12","author":"P Das","year":"2020","unstructured":"Das P, Taube JH (2020) Regulating methylation at H3K27: a trick or treat for cancer cell plasticity. Cancers (Basel) 12(10):2792","journal-title":"Cancers (Basel)"},{"issue":"3","key":"7257_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11060-017-2477-x","volume":"133","author":"RJ Diaz","year":"2017","unstructured":"Diaz RJ, Ali S, Qadir MG, De La Fuente MI, Ivan ME, Komotar RJ (2017) The role of bevacizumab in the treatment of glioblastoma. J Neurooncol 133(3):455\u2013467","journal-title":"J Neurooncol"},{"issue":"1","key":"7257_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/iub.2620","volume":"75","author":"G Fontemaggi","year":"2023","unstructured":"Fontemaggi G (2023) Non-coding RNA regulatory networks in post-transcriptional regulation of VEGFA in cancer. IUBMB Life 75(1):30\u201339","journal-title":"IUBMB Life"},{"issue":"20","key":"7257_CR15","doi-asserted-by":"publisher","first-page":"e183391","DOI":"10.1172\/JCI183391","volume":"134","author":"S Gold","year":"2024","unstructured":"Gold S, Shilatifard A (2024) Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges. J Clin Invest 134(20):e183391","journal-title":"J Clin Invest"},{"issue":"10","key":"7257_CR16","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s43018-023-00620-0","volume":"4","author":"S Goswami","year":"2023","unstructured":"Goswami S, Raychaudhuri D, Singh P et al (2023) Myeloid-specific KDM6B Inhibition sensitizes glioblastoma to PD1 Blockade. Nat Cancer 4(10):1455\u20131473","journal-title":"Nat Cancer"},{"issue":"6","key":"7257_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N et al (2015) Functionally defined therapeutic targets in diffuse intrinsic Pontine glioma. Nat Med 21(6):555\u2013559","journal-title":"Nat Med"},{"key":"7257_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/ot9.0000000000000092","author":"Y Guo","year":"2025","unstructured":"Guo Y, Guo D (2025) Advances in antiangiogenic therapy for glioblastoma: from mechanisms to clinical translation. Oncol Transl Med. https:\/\/doi.org\/10.1097\/ot9.0000000000000092","journal-title":"Oncol Transl Med"},{"issue":"2","key":"7257_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/abbs\/gmu122","volume":"47","author":"X Guo","year":"2015","unstructured":"Guo X, Tian Z, Wang X et al (2015) Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2\u03b1. Acta Biochim Biophys Sin (Shanghai) 47(2):106\u2013113","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"12","key":"7257_CR20","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.3716","volume":"20","author":"R Hashizume","year":"2014","unstructured":"Hashizume R, Andor N, Ihara Y et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20(12):1394\u20131396","journal-title":"Nat Med"},{"key":"7257_CR21","doi-asserted-by":"publisher","first-page":"779918","DOI":"10.3389\/fonc.2021.779918","volume":"11","author":"C Hua","year":"2021","unstructured":"Hua C, Chen J, Li S, Zhou J, Fu J, Sun W, Wang W (2021) KDM6 demethylases and their roles in human cancers. Front Oncol 11:779918","journal-title":"Front Oncol"},{"issue":"8","key":"7257_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrn2175","volume":"8","author":"RK Jain","year":"2007","unstructured":"Jain RK, di Tomaso E, Duda DG et al (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8(8):610\u2013622","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"7257_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","volume":"12","author":"B Keith","year":"2011","unstructured":"Keith B, Johnson RS, Simon MC (2011) HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12(1):9\u201322","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"7257_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/PPO.0000000000000326","volume":"24","author":"MM Kim","year":"2018","unstructured":"Kim MM, Umemura Y, Leung D (2018) Bevacizumab and glioblastoma: past, present, and future directions. Cancer J 24(4):180\u2013186","journal-title":"Cancer J"},{"issue":"8","key":"7257_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","volume":"12","author":"C Lange","year":"2016","unstructured":"Lange C, Storkebaum E, de Almod\u00f3var CR, Dewerchin M, Carmeliet P (2016) Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol 12(8):439\u2013454","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"7257_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2014.05.019","volume":"26","author":"HJ Lee","year":"2014","unstructured":"Lee HJ, Zhuang G, Cao Y, Du P, Kim HJ, Settleman J (2014) Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells. Cancer Cell 26(2):207\u2013221","journal-title":"Cancer Cell"},{"issue":"1","key":"7257_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14791\/btrt.2017.5.1.1","volume":"5","author":"Y Li","year":"2017","unstructured":"Li Y, Ali S, Clarke J, Cha S (2017) Bevacizumab in recurrent glioma: patterns of treatment failure and implications. Brain Tumor Res Treat 5(1):1\u20139","journal-title":"Brain Tumor Res Treat"},{"issue":"11","key":"7257_CR28","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1161\/ATVBAHA.120.315214","volume":"40","author":"OH Liu","year":"2020","unstructured":"Liu OH, Kiema M, Beter M, Yl\u00e4-Herttuala S, Laakkonen JP, Kaikkonen MU (2020) Hypoxia-mediated regulation of histone demethylases affects angiogenesis-associated functions in endothelial cells. Arterioscler Thromb Vasc Biol 40(11):2665\u20132677","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"7257_CR29","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou F, Ali H, Lathia JD, Chen P (2024) Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell Mol Immunol 21(12):1354\u20131375","journal-title":"Cell Mol Immunol"},{"key":"7257_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-2403-6_1","volume":"2514","author":"E Marques Dos Reis","year":"2022","unstructured":"Marques Dos Reis E, Vieira Berti F (2022) Vasculogenic mimicry-an overview. Methods Mol Biol 2514:3\u201313","journal-title":"Methods Mol Biol"},{"issue":"1","key":"7257_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10456-016-9527-4","volume":"20","author":"TD Nauta","year":"2017","unstructured":"Nauta TD, van den Broek M, Gibbs S et al (2017) Identification of HIF-2\u03b1-regulated genes that play a role in human microvascular endothelial sprouting during prolonged hypoxia in vitro. Angiogenesis 20(1):39\u201354","journal-title":"Angiogenesis"},{"issue":"12","key":"7257_CR32","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S1474-4422(08)70260-6","volume":"7","author":"AD Norden","year":"2008","unstructured":"Norden AD, Drappatz J, Wen PY (2008) Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol 7(12):1152\u20131160","journal-title":"Lancet Neurol"},{"issue":"2","key":"7257_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00018-017-2596-8","volume":"75","author":"MR Pan","year":"2018","unstructured":"Pan MR, Hsu MC, Chen LT, Hung WC (2018) Orchestration of H3K27 methylation: mechanisms and therapeutic implication. Cell Mol Life Sci 75(2):209\u2013223","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"7257_CR34","first-page":"e1318","volume":"5","author":"F Pezzella","year":"2022","unstructured":"Pezzella F, Ribatti D (2022) Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies. Cancer Rep (Hoboken) 5(12):e1318","journal-title":"Cancer Rep (Hoboken)"},{"issue":"2","key":"7257_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/jcmm.12496","volume":"19","author":"L Qiao","year":"2015","unstructured":"Qiao L, Liang N, Zhang J, Xie J, Liu F, Xu D, Yu X, Tian Y (2015) Advanced research on vasculogenic mimicry in cancer. J Cell Mol Med 19(2):315\u2013326","journal-title":"J Cell Mol Med"},{"issue":"3","key":"7257_CR36","doi-asserted-by":"publisher","first-page":"e12602","DOI":"10.1111\/micc.12602","volume":"27","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R (2020) Epigenetic control of tumor angiogenesis. Microcirculation 27(3):e12602","journal-title":"Microcirculation"},{"issue":"6","key":"7257_CR37","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/cancers11060878","volume":"11","author":"M Romani","year":"2019","unstructured":"Romani M, Daga A, Forlani A, Pistillo MP, Banelli B (2019) Targeting of histone demethylases KDM5A and KDM6B inhibits the proliferation of temozolomide-resistant glioblastoma cells. Cancers (Basel) 11(6):878","journal-title":"Cancers (Basel)"},{"issue":"2","key":"7257_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/revneuro-2020-0062","volume":"32","author":"H Seyedmirzaei","year":"2020","unstructured":"Seyedmirzaei H, Shobeiri P, Turgut M, Hanaei S, Rezaei N (2020) VEGF levels in patients with glioma: a systematic review and meta-analysis. Rev Neurosci 32(2):191\u2013202","journal-title":"Rev Neurosci"},{"issue":"10","key":"7257_CR40","doi-asserted-by":"publisher","first-page":"17990","DOI":"10.1002\/jcp.28431","volume":"234","author":"A Sui","year":"2019","unstructured":"Sui A, Xu Y, Pan B, Guo T, Wu J, Shen Y, Yang J, Guo X (2019a) Histone demethylase KDM6B regulates 1,25-dihydroxyvitamin D3-induced senescence in glioma cells. J Cell Physiol 234(10):17990\u201317998","journal-title":"J Cell Physiol"},{"key":"7257_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuint.2019.01.006","volume":"124","author":"A Sui","year":"2019","unstructured":"Sui A, Xu Y, Yang J, Pan B, Wu J, Guo T, Shen Y, Guo X (2019b) The histone H3 Lys 27 demethylase KDM6B promotes migration and invasion of glioma cells partly by regulating the expression of SNAI1. Neurochem Int 124:123\u2013129","journal-title":"Neurochem Int"},{"issue":"5","key":"7257_CR39","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s12031-022-01976-1","volume":"72","author":"A Sui","year":"2022","unstructured":"Sui A, Han B, Ren W, He W, Gao C, Han X, Liu S, Zhang Y, Qi X, Guo X (2022) The epigenetic regulation of OLIG2 by histone demethylase KDM6B in glioma cells. J Mol Neurosci 72(5):939\u2013946","journal-title":"J Mol Neurosci"},{"issue":"1","key":"7257_CR42","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.1038\/s41598-021-88000-5","volume":"11","author":"A S\u00e1nchez-Navarro","year":"2021","unstructured":"S\u00e1nchez-Navarro A, P\u00e9rez-Villalva R, Murillo-de-Ozores AR et al (2021) VEGFA promoter gene hypermethylation at HIF1\u03b1 binding site is an early contributor to CKD progression after renal ischemia. Sci Rep 11(1):8769","journal-title":"Sci Rep"},{"issue":"8","key":"7257_CR43","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1634\/theoncologist.2012-0068","volume":"17","author":"S Tejpar","year":"2012","unstructured":"Tejpar S, Prenen H, Mazzone M (2012) Overcoming resistance to antiangiogenic therapies. Oncologist 17(8):1039\u20131050","journal-title":"Oncologist"},{"issue":"10","key":"7257_CR44","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s44161-024-00546-5","volume":"3","author":"N Tetik-Elsherbiny","year":"2024","unstructured":"Tetik-Elsherbiny N, Elsherbiny A, Setya A et al (2024) RNF20-mediated transcriptional pausing and VEGFA splicing orchestrate vessel growth. Nat Cardiovasc Res 3(10):1199\u20131216","journal-title":"Nat Cardiovasc Res"},{"key":"7257_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jocn.2017.06.070","volume":"44","author":"M Tipping","year":"2017","unstructured":"Tipping M, Eickhoff J, Ian Robins H (2017) Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: an analysis of the literature. J Clin Neurosci 44:101\u2013106","journal-title":"J Clin Neurosci"},{"issue":"3","key":"7257_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/cvr\/cvr109","volume":"90","author":"MP Turunen","year":"2011","unstructured":"Turunen MP, Yl\u00e4-Herttuala S (2011) Epigenetic regulation of key vascular genes and growth factors. Cardiovasc Res 90(3):441\u2013446","journal-title":"Cardiovasc Res"},{"issue":"2","key":"7257_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11060-019-03314-9","volume":"145","author":"S Vera","year":"2019","unstructured":"Vera S, Sinning M, Vergara M, Lemus D, Rosas C (2019) Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study. J Neurooncol 145(2):233\u2013239","journal-title":"J Neurooncol"},{"issue":"11","key":"7257_CR48","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1080\/00207454.2023.2276656","volume":"134","author":"H Wang","year":"2024","unstructured":"Wang H, Guo B, Guo X (2024) Histone demethylases in neurodevelopment and neurodegenerative diseases. Int J Neurosci 134(11):1372\u20131382","journal-title":"Int J Neurosci"},{"key":"7257_CR49","doi-asserted-by":"crossref","unstructured":"Wang H, Guo J, Wang T, Wang K, Wu Z, Sun T (2021) Efficacy and safety of bevacizumab in the treatment of adult gliomas: a systematic review and meta-analysis. BMJ Open 11(12):e048975","DOI":"10.1136\/bmjopen-2021-048975"},{"issue":"1","key":"7257_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","volume":"20","author":"X Wei","year":"2021","unstructured":"Wei X, Chen Y, Jiang X et al (2021) Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer 20(1):7","journal-title":"Mol Cancer"},{"key":"7257_CR51","doi-asserted-by":"publisher","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","volume":"1","author":"M Weller","year":"2015","unstructured":"Weller M, Wick W, Aldape K et al (2015) Glioma Nat Rev Dis Primers 1:15017","journal-title":"Glioma Nat Rev Dis Primers"},{"key":"7257_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.gde.2016.11.001","volume":"43","author":"ET Wiles","year":"2017","unstructured":"Wiles ET, Selker EU (2017) H3K27 methylation: a promiscuous repressive chromatin mark. Curr Opin Genet Dev 43:31\u201337","journal-title":"Curr Opin Genet Dev"}],"container-title":["Experimental Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-026-07257-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00221-026-07257-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-026-07257-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:02:50Z","timestamp":1775120570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00221-026-07257-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7257"],"URL":"https:\/\/doi.org\/10.1007\/s00221-026-07257-2","relation":{},"ISSN":["0014-4819","1432-1106"],"issn-type":[{"value":"0014-4819","type":"print"},{"value":"1432-1106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Ethics Committee of Hebei General Hospital (No. 2022106). Participants consented to be identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"54"}}